Global menu

Our global pages

Close

Eversheds Sutherland advised H2 Equity Partners on the acquisition of Acquilant

  • Ireland
  • General

23-08-2018

Eversheds Sutherland advised H2 Equity Partners on the acquisition of Aquilant from Dublin based UDG Healthcare for a potential consideration of up to €23 million.

Aquilant is a distributor of specialist medical, pharmaceutical and scientific products and services, including outsourced sales, marketing, distribution and engineering services to clients in Ireland, the UK and the Netherlands.

The Eversheds Sutherland team was led by James Trevis, Richard Kyle and Elizabeth Tindall (Corporate) with support from across our English, Dublin and Belfast offices from Thomas Howell and Amy McDermott (Corporate), Kathryn Walters, Ben Riding, Piaras Power and Ann Kilbane (Banking), Gavin O'Flaherty (Corporate), Gareth Planck (Real Estate), Lisa Bryson (HR), Ben Jones and Colin Askew (Tax).

Disclaimer

This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

< Go back

Print Friendly and PDF
Register to receive regular updates via email.